A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the relative efficacy and safety of prasugrel and clopidogrel in a
medically managed Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) acute
coronary syndrome (ACS) population (that is, patients who are not managed with acute coronary
revascularization).
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborators:
Daiichi Sankyo Co., Ltd. Duke Clinical Research Institute